<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T4" orientation="portrait" position="float">
 <label>Table 4</label>
 <caption>
  <p>Chloroquine and its combination of drugs used in the treatment of COVID-19</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th valign="middle" align="center" rowspan="1" colspan="1">Study Particulars</th>
    <th valign="middle" align="center" rowspan="1" colspan="1">Drugs</th>
    <th valign="middle" align="center" rowspan="1" colspan="1">Dosage</th>
    <th valign="middle" align="center" rowspan="1" colspan="1">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Chloroquine (C) phosphate against pneumonia caused by COVID-19 but need confirmation through randomized trials</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Chloroquine phosphate</td>
    <td valign="top" align="center" rowspan="1" colspan="1">Not specified</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">15</td>
   </tr>
   <tr>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">SARS-CoV-2 and blocked viral infection by increasing the endosomal pH required for viral fusion</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Chloroquine</td>
    <td valign="top" align="center" rowspan="1" colspan="1">1.13 μM at half maximal concentration</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">27 (Nichol 
     <italic>et al</italic>., 2020)
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Chloroquine (C) and Hydroxychloroquine (HC) are under investigation in clinical trials for pre-exposure or post-exposure prophylaxis of SARS-CoV-2 infection, and treatment of patients with mild, moderate, and severe COVID-19 </td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Chloroquine and Hydroxychloroquine</td>
    <td valign="top" align="center" rowspan="1" colspan="1">Not specified</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">8</td>
   </tr>
   <tr>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">C and HC inhibit in vitro replication of viruses which envelope fuses with that of the acidified endosome. The in vitro antiviral activity of C and HC against SARS-CoV-2 reported </td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Chloroquine and Hydroxychloroquine</td>
    <td valign="top" align="center" rowspan="1" colspan="1">Not specified</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">27 (Nichol 
     <italic>et al</italic>., 2020); 43 (Liu 
     <italic>et al</italic>., 2020)
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Prescribing Hydroxychloroquine treatment on a large scale, and decided to perform a study aimed at demonstrating that HC is effective in vivo against SARS-CoV-2</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Hydroxychloroquine</td>
    <td valign="top" align="center" rowspan="1" colspan="1">Not specified</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">31 (Parola 
     <italic>et al</italic>., 2020)
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Azithromycin–suggested to act in combination with C/HC against SARs-CoV-2</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Azithromycin + Chloroquine + Hydroxychloroquine</td>
    <td valign="top" align="center" rowspan="1" colspan="1">Not specified</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">31 (Parola 
     <italic>et al</italic>., 2020)
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Two drugs, remdesivir and chloroquine phosphate, efficiently inhibited SARS-CoV-2 infection in vitro</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Remdesivir + chloroquine phosphate</td>
    <td valign="top" align="center" rowspan="1" colspan="1">Not specified</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">27 (Nichol 
     <italic>et al</italic>., 2020)
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">COVID-19 pneumonia and without contraindications to chloroquine, be treated with 500 mg chloroquine twice a day for ten days</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Chloroquine</td>
    <td valign="top" align="center" rowspan="1" colspan="1">500 mg twice a day</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">31 (Parola 
     <italic>et al</italic>., 2020)
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Hydroxychloroquine is recommended for high-risk COVID-19 cases</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Hydroxychloroquine</td>
    <td valign="top" align="center" rowspan="1" colspan="1">Not specified</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">32 (Hoffman 
     <italic>et al</italic>., 2006)
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">HC and C demonstrated antiviral activity against SARS–CoV-2 in vitro and in small, poorly controlled or uncontrolled clinical studies</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Chloroquine and Hydroxychloroquine</td>
    <td valign="top" align="center" rowspan="1" colspan="1">Not specified</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">22 (Zhang 
     <italic>et al</italic>., 2020)
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Reducing symptom duration, exacerbation of pneumonia including radiological improvement and promoting virus-negative seroconversion without any severe side effects in COVID-19</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">Chloroquine</td>
    <td valign="top" align="center" rowspan="1" colspan="1">Not specified</td>
    <td valign="top" align="left" style="padding-left: 15px; text-indent: -15px;" rowspan="1" colspan="1">23 (Yang 
     <italic>et al</italic>., 2020)
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
